Authors: de Carvalho Júlia Ribeiro Garcia, Del Puppo Debora, Littiere Thayssa de Oliveira, de Sales Nathali Adrielli Agassi, Silva Ana Carolina Yamamoto, Ribeiro Gesiane, de Almeida Ferdinando Nielsen, Alves Bruna Gomes, Gatto Igor Renan Honorato, Ramos Gabriel Vieira, Ferraz Guilherme de Camargo
Journal: Frontiers in veterinary science
Summary
# Editorial Summary Researchers induced experimental synovitis in horses to evaluate whether meloxicam administration could mitigate the inflammatory response and associated clinical signs, comparing treated animals against untreated controls across an 8-hour observation period. Joint circumference remained unchanged in both groups, yet horses receiving meloxicam demonstrated significantly lower rectal temperatures 4 hours post-induction and, crucially, showed no clinically detectable lameness at any assessment point, whereas control animals exhibited progressive lameness at 2, 4, and 8 hours. The control group displayed predictable haematological changes—elevated neutrophils alongside reduced haemoglobin and haematocrit at 8 hours—whilst synovial fluid parameters failed to differentiate between treated and untreated joints. These findings suggest that early meloxicam intervention may effectively suppress systemic inflammatory markers and prevent the manifestation of clinical lameness during acute synovitis, though the absence of synovial fluid changes warrants consideration regarding the drug's local joint penetration and whether systemic effects alone account for the observed clinical improvement. For practitioners managing acute joint inflammation, this work supports early NSAID administration to maintain ridden function and reduce pain-related compensatory movement, though further investigation into optimal dosing protocols and longer-term outcomes would strengthen clinical recommendations.
Read the full abstract on PubMed
Practical Takeaways
- •Meloxicam effectively controls lameness from experimentally-induced synovitis and may provide clinical benefit in managing acute joint inflammation cases
- •NSAIDs like meloxicam appear to modulate systemic inflammatory markers (temperature, hemoglobin, neutrophil response) in acute synovitis
- •Joint circumference measurements alone are insufficient to assess inflammatory response; lameness scoring and systemic markers provide better clinical indicators
Key Findings
- •Meloxicam treatment prevented clinically significant lameness at 2, 4, and 8 hours post-synovitis induction, while control group showed progressive lameness
- •Meloxicam-treated horses exhibited lower rectal temperature 4 hours after synovitis induction compared to controls
- •Control group demonstrated increased neutrophils with decreased total hemoglobin and hematocrit 8 hours post-induction, indicating systemic inflammatory response
- •No significant changes in synovial fluid composition were detected between treatment and control groups